For example, we find the TAM differentiation pathway involves increased expression of CD276 (B7-H3), a known immune checkpoint molecule related to impaired CD8+ T-cell anti-tumor cytotoxicity.33 Indeed, CD276 blockade enhanced the effect of PDL1 or PD1 ICB in mouse tumor models.33 47. Here, CD274 is linked to neoplasm.